# Vinorelbine

## Navelbine 20mg

| 藥物代碼           | ONAV2                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Non-small cell lung cancer. Metastatic breast cancer.                                                                                                                                                                                                                                                                                                                                                                                                     |
| 副作用             | Neutropenia, anemia, thrombocytopenia; nausea & vomiting, diarrhea, anorexia, stomatitis, esophagitis; loss of tendon reflexes, neuromotor disorders, neuroconstipation (rarely progressing to paralytic ileus); alopecia; fatigue, fever, arthralgia including jaw pain, myalgia, pain including pain at tumor site. Vial Ischemic cardiac disease (rare), abnormal liver function tests, dyspnea, bronchospasm, generalized cutaneous reactions (rare). |
| 禁忌               | Disease significantly affecting absorption; previous significant surgical resection of stomach or small bowel. Severe hepatic impairment; pregnancy & lactation; patients requiring long-term O2 therapy. Coadministration with meningocococal conjugate vaccine or other live virus vaccines, phenytoin & itraconazole. Pretreatment granulocyte counts <1000/mm3                                                                                        |
| 藥物保存方式       | 2-8℃                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 用法用量           | 60 mg/m2 body surface area, administered once weekly.Beyond the 3rd administration, increase the dose to 80 mg/m2 once weekly, except in patient s whose neutrophil count dropped once below 500/mm3 or more than once between 500 & 1000/mm3 during the 1st 3 administrations at 60mg/m2.                                                                                                                                                                |
| 肝功能異常         | 需 調 整 劑 量  輕度肝功能不全患者(膽紅素<1.5倍,且ALAT 或/和 ASAT 為1.5至2.5倍ULN):每周可給予60mg/m^2 標準劑量 中度肝功能不全患者(膽紅素為1.5 ~ 3 倍,且無論ALAT 和 ASAT 數值為何):每周應給50mg/m^2標準劑量 嚴重肝功能不全患者不建議使用                                                                                                                                                                                                                   |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 懷孕用藥危分級     | 儘量避免                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity(Mother) 無(很少)資料 - 避免使用(母體)                                                                                                                                                                                                                                                                                                                                                                        |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

